FDA
- Status: approved
Continuous Perineural Ropivicaine Infusion (Continuous Perineural Ropivicaine Infusion) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Eric Shepard is the originator. The local marketing authorisation holder may differ — check the official source linked above.